Connect with us

Business

Actinogen share price jumps 4.5% on patent news// Motley Fool Australia

Published

on

ADVERTISEMENT


The Actinogen Medical Ltd (ASX: ACW) share price jumped 4.5% on open this morning, after the company announced it has filed two new patent applications to strengthen and extend its intellectual property (IP) portfolio.  

What does Actinogen Medical do?

Actinogen Medical is an ASX biotech company. It specialises in developing novel therapies of a range of conditions. These include neurological, psychiatric and metabolic diseases associated with chronically elevated cortisol. This is a metabolic disorder caused by overproduction of corticosteroid hormones by the adrenal cortex. Often it is associated with obesity and high blood pressure.

The lead compound currently being developed by Actinogen is called “Xanamem”. This compound…



Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Should you take a bite of these tasty ASX shares?
2 ASX dividend shares with generous 4%+ yields
ASX 200 to rise after positive AstraZeneca COVID-19 vaccine news